# Ribosome Profiling
**Written by Group 5 Zhuolin Jiang, Zeting Li, Keguang Zhang**
## Introduction
<div style="text-align: justify;">
Ribosome profiling, also known as Ribo-seq, is a revolutionary technique that enables genome-wide analysis of translation by mapping ribosome-protected mRNA fragments. This powerful method provides unparalleled insights into gene expression at the level of translation, complementing transcriptomics and proteomics to offer a comprehensive view of cellular function.
</div>

## Why Ribosome Profiling?
<div style="text-align: justify;">
The technique emerged as a solution to a long-standing challenge in molecular biology: precisely monitoring protein translation. RNA-seq, while effective at measuring mRNA levels, fails to capture the complexity of translation due to the lack of correlation between mRNA abundance and protein synthesis rates. Similarly, mass spectrometry, though valuable for identifying and quantifying proteins, provides a static view of already synthesized proteins, missing the dynamic process of translation. Ribosome profiling addresses these shortcomings by capturing translation events in real-time, offering dynamic and positional resolution of ribosome activity. Translation, a highly energy-intensive process, is crucial for cellular function. Dysregulation of translation is associated with diseases such as anemia, autism spectrum disorders, Alzheimer’s disease, and cancer. Since its introduction in 2009 by Ingolia et al., ribosome profiling has advanced our ability to study translation with codon-level precision, offering a more comprehensive understanding of cellular biology compared to RNA-seq and mass spectrometry.
</div>

## Applications of Ribosome Profiling
1. Global Translation Analysis

Ribosome profiling offers a genome-wide view of translation, allowing researchers to quantify translation rates across the entire transcriptome. Unlike RNA-seq, which provides data on transcript abundance, ribosome profiling focuses on actively translated mRNAs, delivering a more accurate picture of gene expression at the protein synthesis level. This approach has been pivotal in studying cell-specific protein production under different conditions, such as stress or developmental stages.

2. Discovery of Alternative ORFs

Ribosome profiling has redefined our understanding of open reading frames (ORFs). It has revealed the widespread presence of upstream ORFs (uORFs) and noncanonical initiation codons, previously undetected by traditional techniques. These findings have significant implications for gene regulation and protein diversity, as uORFs can influence downstream translation. For example, ribosome profiling has identified regulatory mechanisms in cancer biology, where translation from alternative ORFs contributes to tumor progression. Small ORFs (sORFs), previously considered nonfunctional, have also been shown to encode bioactive peptides involved in key cellular processes like metabolism and stress responses.

3. Ribosome Dynamics and Translational Pauses

This technique allows for precise tracking of ribosome movement along mRNA, uncovering codon-specific pauses that are often regulatory. Ribosome profiling has been used to study co-translational folding of nascent polypeptides and how these pauses affect protein structure and function. Pausing can also reveal regulatory mechanisms like feedback loops in biosynthetic pathways, such as the regulation of arginine biosynthesis through ribosome stalling.

4. Insights into ncRNAs and cancer researches

There are many gene expression changes in cancer, and ribosome profiling provides a unique window into understanding these changes at the translational level. One key area is the translational potential of transcripts previously classified as noncoding RNAs (ncRNAs). For instance, studies have shown that LINC00493, annotated as ncRNA, encodes a peptide localized to mitochondria, interacting with critical mitochondrial proteins. These findings suggest that many annotated ncRNAs may have unrecognized functional roles.

In the context of cancer, ribosome profiling aids in identifying disease-specific translational changes and novel therapeutic targets. Cancer is characterized by significant changes in glucose metabolism and aberrant amino acid metabolism. Ribosome profiling has helped uncover these metabolic shifts by revealing the translational regulation behind them. For instance, it has enabled the identification of somatic mutations and dysregulated oncogenic pathways involved in tumorigenesis. 

By analyzing ribosome profiling data, Huang et al. speculated that HOXB-AS3, a downregulated lncRNA in colorectal cancer (CRC) tissues, might serve as a potential protein-coding template. Subsequent experiments revealed that HOXB-AS3 encodes a 55-amino acid peptide, which exerts its tumor-suppressive role by competitively impairing the binding of splicing factor heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) to PKM exon 9. This interaction favors the formation of PKM1 over PKM2, leading to impaired aerobic glycolysis and inhibition of CRC growth. These discoveries not only expand our understanding of tumor biology but also highlight potential biomarkers and drug targets.

5. Integration with Other Technologies

When combined with advanced RNA immunoprecipitation techniques such as RIP-seq, MeRIP-seq, or acRIP-seq, ribosome profiling provides critical insights into how RNA-binding proteins, RNA methylation, and RNA acetylation regulate translational efficiencies of specific transcripts. These combined approaches deepen our understanding of gene regulation at the translational level, enabling precise modulation of translational machinery. When integrated with CRISPR-Cas9 and proteomics, ribosome profiling not only reveals intricate regulatory networks but also drives innovations in synthetic biology and personalized medicine.

## References
Bao Y, Zhai J, Chen H, Wong CC, Liang C, Ding Y, et al. Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut. 2023;72(8):1497–509.

Brar, G. A., & Weissman, J. S. (2015). Ribosome profiling reveals the what, when, where, and how of protein synthesis. Nature Reviews Molecular Cell Biology, 16(11), 651-664.

Choi SH, Martinez TF, Kim S, Donaldson C, Shokhirev MN, Saghatelian A, et al. CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability. Genes Dev. 2019;33(7–8):418–35.

Huang JZ, Chen M, Chen D, Gao XC, Zhu S, Huang H, et al. A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth. Mol Cell. 2017;68(1):171–84.e6.

Ingolia, N. T., et al. (2009). Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science, 324(5924), 218-223.

Su, D., Ding, C., Qiu, J., Yang, G., Wang, R., Liu, Y., ... & Zhang, T. (2024). Ribosome profiling: a powerful tool in oncological research. Biomarker Research, 12(1), 11.

Wei R, Cui X, Min J, Lin Z, Zhou Y, Guo M, et al. NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma. Acta Pharm Sin B. 2022;12(8):3313-25.



